Matches in Wikidata for { <http://www.wikidata.org/entity/Q92533306> ?p ?o ?g. }
Showing items 1 to 70 of
70
with 100 items per page.
- Q92533306 description "article scientifique publié en 2019" @default.
- Q92533306 description "artículu científicu espublizáu en xunetu de 2019" @default.
- Q92533306 description "scientific article published on 01 July 2019" @default.
- Q92533306 description "wetenschappelijk artikel" @default.
- Q92533306 description "наукова стаття, опублікована 1 липня 2019" @default.
- Q92533306 name "Correction to: Phase I-II trial of imatinib mesylate (Gleevec; STI571) in treatment of recurrent oligodendroglioma and mixed oligoastrocytoma. North central cancer treatment group study N0272 (ALLIANCE/NCCTG)" @default.
- Q92533306 name "Correction to: Phase I-II trial of imatinib mesylate (Gleevec; STI571) in treatment of recurrent oligodendroglioma and mixed oligoastrocytoma. North central cancer treatment group study N0272 (ALLIANCE/NCCTG)" @default.
- Q92533306 type Item @default.
- Q92533306 label "Correction to: Phase I-II trial of imatinib mesylate (Gleevec; STI571) in treatment of recurrent oligodendroglioma and mixed oligoastrocytoma. North central cancer treatment group study N0272 (ALLIANCE/NCCTG)" @default.
- Q92533306 label "Correction to: Phase I-II trial of imatinib mesylate (Gleevec; STI571) in treatment of recurrent oligodendroglioma and mixed oligoastrocytoma. North central cancer treatment group study N0272 (ALLIANCE/NCCTG)" @default.
- Q92533306 prefLabel "Correction to: Phase I-II trial of imatinib mesylate (Gleevec; STI571) in treatment of recurrent oligodendroglioma and mixed oligoastrocytoma. North central cancer treatment group study N0272 (ALLIANCE/NCCTG)" @default.
- Q92533306 prefLabel "Correction to: Phase I-II trial of imatinib mesylate (Gleevec; STI571) in treatment of recurrent oligodendroglioma and mixed oligoastrocytoma. North central cancer treatment group study N0272 (ALLIANCE/NCCTG)" @default.
- Q92533306 P1433 Q92533306-178AD639-4894-43FC-9AA8-9B15E8982CEA @default.
- Q92533306 P1476 Q92533306-F88A2B4C-B86C-4092-A312-89BEC15B9AFC @default.
- Q92533306 P2093 Q92533306-1BF26037-BAAE-49F3-AB70-BAC46FBB186C @default.
- Q92533306 P2093 Q92533306-35854807-3F76-4C8B-85D8-A832EE9869A3 @default.
- Q92533306 P2093 Q92533306-4BE8AC81-B341-4043-994B-01EEDD1D41E3 @default.
- Q92533306 P2093 Q92533306-552DDD55-7FF1-4E0E-AD5D-A828CDF80958 @default.
- Q92533306 P2093 Q92533306-876E2897-9E80-4DDA-A7FA-A66B8D336F8E @default.
- Q92533306 P2093 Q92533306-9F3B231C-C48B-4D6F-B287-BBC18F37FE21 @default.
- Q92533306 P2093 Q92533306-B148EB85-A619-4F76-9C4D-120512E5C2A3 @default.
- Q92533306 P2093 Q92533306-B5002465-467C-44E0-A805-8AC1BD05D8D3 @default.
- Q92533306 P2093 Q92533306-C328BB96-5EF0-469A-9278-CB20D27DC1E0 @default.
- Q92533306 P2093 Q92533306-E03A6BAF-B18D-4F0B-88BB-EFED72C97F32 @default.
- Q92533306 P2093 Q92533306-E0B5F619-AA17-4F56-9EE5-41468D0A9240 @default.
- Q92533306 P2093 Q92533306-EC8028AE-1A0D-4637-9B6E-ECF2AF0B0FF0 @default.
- Q92533306 P304 Q92533306-31570F9E-81B4-4DE5-B8BB-433201425CAB @default.
- Q92533306 P31 Q92533306-04C2B32B-4140-4C65-8BFE-4F91E9B576A6 @default.
- Q92533306 P31 Q92533306-B432B10A-7393-42C0-BE15-F731503E7315 @default.
- Q92533306 P356 Q92533306-528404CB-AA6C-4FAC-BD4A-6C6478FF2DA7 @default.
- Q92533306 P433 Q92533306-6CD9FAB5-7311-4FA9-96B7-26AB6DF06A8C @default.
- Q92533306 P478 Q92533306-456F0F72-D949-40DE-BD3D-551A3417DFBE @default.
- Q92533306 P50 Q92533306-11D72C1D-3414-4C57-B44B-EBB73335A138 @default.
- Q92533306 P577 Q92533306-6D376FEB-A488-4230-BDFB-7FAA70100A8E @default.
- Q92533306 P698 Q92533306-DAEC3E76-080E-4F8A-B2CB-DB06DF971BCD @default.
- Q92533306 P921 Q92533306-56AA177B-BB2A-4769-9FC5-A0C8E6DEB06E @default.
- Q92533306 P921 Q92533306-7D089458-129A-44CA-AD51-652EE32CE149 @default.
- Q92533306 P921 Q92533306-EC13AD9A-78F3-4E05-BCD6-BA2144A59471 @default.
- Q92533306 P921 Q92533306-EFF0D9B0-E35B-435D-A733-5CE23E3CDE09 @default.
- Q92533306 P932 Q92533306-1B4866DF-B040-4966-8EFD-1949DC058804 @default.
- Q92533306 P356 S11060-019-03201-3 @default.
- Q92533306 P698 31165953 @default.
- Q92533306 P1433 Q15752119 @default.
- Q92533306 P1476 "Correction to: Phase I-II trial of imatinib mesylate (Gleevec; STI571) in treatment of recurrent oligodendroglioma and mixed oligoastrocytoma. North central cancer treatment group study N0272 (ALLIANCE/NCCTG)" @default.
- Q92533306 P2093 "Caterina Giannini" @default.
- Q92533306 P2093 "Erin L Twohy" @default.
- Q92533306 P2093 "Evanthia Galanis" @default.
- Q92533306 P2093 "Jan C Buckner" @default.
- Q92533306 P2093 "Jann N Sarkaria" @default.
- Q92533306 P2093 "Jesse G Dixon" @default.
- Q92533306 P2093 "John Schwerkoske" @default.
- Q92533306 P2093 "Merrill J Egorin" @default.
- Q92533306 P2093 "P J Flynn" @default.
- Q92533306 P2093 "Paul D Brown" @default.
- Q92533306 P2093 "Robert Jenkins" @default.
- Q92533306 P2093 "S K Anderson" @default.
- Q92533306 P304 "583" @default.
- Q92533306 P31 Q13442814 @default.
- Q92533306 P31 Q1348305 @default.
- Q92533306 P356 "10.1007/S11060-019-03201-3" @default.
- Q92533306 P433 "3" @default.
- Q92533306 P478 "143" @default.
- Q92533306 P50 Q92232353 @default.
- Q92533306 P577 "2019-07-01T00:00:00Z" @default.
- Q92533306 P698 "31165953" @default.
- Q92533306 P921 Q1318384 @default.
- Q92533306 P921 Q177094 @default.
- Q92533306 P921 Q18555324 @default.
- Q92533306 P921 Q5452194 @default.
- Q92533306 P932 "6739071" @default.